Carcinostatic or antitumor antibiotic, conagenin, and...

Details Carcinostatic or antitumor antibiotic, conagenin, and... Carcinostatic or antitumor antibiotic, conagenin, and...

C - Chemistry, Metallurgy

12

P

195/101, 167/261

C12P 13/02 (2006.01) A61K 31/19 (2006.01) C07C 235/12 (2006.01) C12N 1/20 (2006.01)

Patent

CA 2017276

A new antibiotic, named Conagenin, is provided which can exhibit useful carcinostatic or antitumor activities on carcinomas and tumors, particularly malignant tumors, of mammalian animals including man. Conagenin can be produced by fermentation of microorganisms of genus Streptomyces, typically Streptomyces roseosporus MI696-AF3 strain identified under the deposit number FERM BP-2738. Conagenin has formula (I) and is useful for medicinal purposes, particularly as carcinostatic agent or antitumor agent for inhibiting carcinomas and malignant tumors of mammalian animals, including man.

Affiliated with

Also associated with

Rating

Carcinostatic or antitumor antibiotic, conagenin, and... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Carcinostatic or antitumor antibiotic, conagenin, and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carcinostatic or antitumor antibiotic, conagenin, and... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1550158